Literature DB >> 20174843

MAGE-A antigens in lesions of the oral mucosa.

Eva Krauss1, Stephan Rauthe, Stefan Gattenlöhner, Tobias Reuther, Michael Kochel, Ulrike Kriegebaum, Alexander C Kübler, Urs D A Müller-Richter.   

Abstract

Oral squamous cell carcinoma develops continuously out of predamaged oral mucosa. For the physician and pathologist, difficulties arise in distinguishing precancerous from cancerous lesions. MAGE-A antigens are tumor antigens that are found solely in malignant transformed cells. These antigens might be useful in distinguishing precancerous from cancerous lesions. The aim of this study was to verify this assumption by comparing MAGE-A expression in benign, precancerous, and cancerous lesions of the oral mucosa. Retrospectively, biopsies of different oral lesions were randomly selected. The lesions that were included are 64 benign oral lesions (25 traumatic lesions (oral ulcers), 13 dental follicles, and 26 epulis), 26 oral lichen planus, 123 epithelial precursor lesions (32 epithelial hyperplasia found in leukoplakias, 24 epithelial dysplasia found in leukoplakias, 26 erythroplasia with oral epithelial dysplasia, and 41 carcinomas in situ in erythroleukoplakias). The lesions were immunohistochemically stained with the poly-MAGE-A antibody 57B, and the results were compared. Biopsies of oral lichen planus, oral ulcers, dental follicles, epulis, and leukoplakia without dysplasia showed no positive staining for MAGE-A antigens. Leukoplakia with dysplasia, dysplasia, and carcinomata in situ displayed positive staining in 33%, 65%, and 56% of the cases, respectively. MAGE-A antigens were not detectable via immunohistochemistry in benign lesions of the oral mucosa. The staining rate of dysplastic precancerous lesions or malignant lesions ranged from 33% to 65%. The MAGE-A antigens might facilitate better differentiation between precancerous and cancerous lesions of the oral mucosa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174843     DOI: 10.1007/s00784-010-0387-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  32 in total

1.  Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.

Authors:  Adam Gondos; Volker Arndt; Bernd Holleczek; Christa Stegmaier; Hartwig Ziegler; Hermann Brenner
Journal:  Int J Cancer       Date:  2007-07-15       Impact factor: 7.396

2.  Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.

Authors:  Jutta Ries; Stefan Schultze-Mosgau; Friedrich Neukam; Elke Diebel; Joerg Wiltfang
Journal:  Int J Oncol       Date:  2005-03       Impact factor: 5.650

3.  Projections of alcohol- and tobacco-related cancer mortality in Central Europe.

Authors:  I Bray; P Brennan; P Boffetta
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

4.  Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract.

Authors:  Mia Hashibe; Paolo Boffetta; David Zaridze; Oxana Shangina; Neonila Szeszenia-Dabrowska; Dana Mates; Vladimir Janout; Eleonóra Fabiánová; Vladimir Bencko; Norman Moullan; Amelie Chabrier; Rayjean Hung; Janet Hall; Federico Canzian; Paul Brennan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-04       Impact factor: 4.254

Review 5.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

6.  Is there a natural limit of the transformation rate of oral leukoplakia?

Authors:  Christian Scheifele; Peter A Reichart
Journal:  Oral Oncol       Date:  2003-07       Impact factor: 5.337

7.  Expression of melanoma-associated antigens in oral squamous cell carcinoma.

Authors:  Jutta Ries; Eleftherios Vairaktaris; Nur Mollaoglu; Joerg Wiltfang; Friedrich W Neukam; Emeka Nkenke
Journal:  J Oral Pathol Med       Date:  2008-02       Impact factor: 4.253

8.  The burden of cancer attributable to alcohol drinking.

Authors:  Paolo Boffetta; Mia Hashibe; Carlo La Vecchia; Witold Zatonski; Jürgen Rehm
Journal:  Int J Cancer       Date:  2006-08-15       Impact factor: 7.396

9.  Head and neck cancer, treatment, evolution and post therapeutic survival - Part 2: a decade's results 1993-2002.

Authors:  Teofil Lung; Oana Cristina Tăşcău; Horea Artimoniu Almăşan; Ovidiu Mureşan
Journal:  J Craniomaxillofac Surg       Date:  2007-04-20       Impact factor: 2.078

10.  Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines.

Authors:  Urs D A Müller-Richter; Albert Dowejko; Tobias Reuther; Johannes Kleinheinz; Torsten E Reichert; Oliver Driemel
Journal:  Head Face Med       Date:  2009-04-09       Impact factor: 2.151

View more
  7 in total

1.  The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa.

Authors:  Roman C Brands; Olga Köhler; Stephan Rauthe; Stefan Hartmann; Harald Ebhardt; Axel Seher; Christian Linz; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2016-09-08       Impact factor: 3.573

2.  Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.

Authors:  S Hartmann; U Kriegebaum; N Küchler; R C Brands; C Linz; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2013-02-21       Impact factor: 3.573

3.  MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.

Authors:  Till J Meyer; Stefan Hartmann; Gisela Wohlleben; Muna Brisam; Axel Seher; Alexander C Kübler; Bülent Polat; Urs D A Müller-Richter
Journal:  Mol Clin Oncol       Date:  2018-01-19

4.  Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma.

Authors:  Stefan Hartmann; Muna Brisam; Stephan Rauthe; Oliver Driemel; Roman C Brands; Andreas Rosenwald; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

5.  Melanoma-associated antigen expression and the efficacy of tyrosine kinase inhibitors in head and neck cancer.

Authors:  Stefan Hartmann; Roman C Brands; Nora Küchler; Andreas Fuchs; Christian Linz; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

6.  Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial.

Authors:  Felix Peter Koch; Peer W Kaemmerer; Stefan Biesterfeld; Martin Kunkel; Wilfried Wagner
Journal:  Clin Oral Investig       Date:  2010-08-17       Impact factor: 3.573

7.  Malignant transformation of oral leukoplakia is associated with macrophage polarization.

Authors:  Manuel Weber; Falk Wehrhan; Christoph Baran; Abbas Agaimy; Maike Büttner-Herold; Hatice Öztürk; Kristina Neubauer; Claudia Wickenhauser; Marco Kesting; Jutta Ries
Journal:  J Transl Med       Date:  2020-01-07       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.